Granules India informs about press release

05 Mar 2026 Evaluate
Granules India has enclosed a copy of Press Release titled ‘Granules India’s Packaging Facility in US gets FDA EIR with No Action Indicated Status’.

The above information is a part of company’s filings submitted to BSE.

Granules India Share Price

619.00 5.00 (0.81%)
06-Apr-2026 11:11 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.90
Dr. Reddys Lab 1198.00
Cipla 1171.70
Zydus Lifesciences 855.65
Lupin 2245.35
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×